By immunohistochemistry, Jeschke et al. discovered a considerable elevation of gal-1 and gal-3 expression on EVT in placentas from patients with preeclampsia or HELLP, but no significant change was seen in FGR placentas compared to normal controls [137]. The gene discussed is LGALS1; the disease is preeclampsia.